CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 20 August 2018; it is no longer maintained. See further, timeline and commentary. Case facts Outline European Commission merger investigation into the proposed merger between Praxair and Linde (Case M.8480). The transaction involves horizontal overlaps in markets for the supply of gases. Latest developments On 20 August 2018, the Commission conditionally cleared the transaction following an in-depth phase II investigation. Under the commitments, the parties have agreed to (i) divest Praxair’s entire EEA gas business (including industrial, medical, specialty gases and helium); (ii) divest Praxair’s stake in a JV called SIAD to the co-shareholder Flow Fin; and (iii) divest additional helium sourcing contracts to address helium-related competition concerns on a world-wide level. Parties The Linde Group (Linde) is headquartered in Germany and active in over 100 countries worldwide in the supply of industrial gases, medical gases, speciality gases and related services, including engineering. Praxair Inc (Praxair) is headquartered in the United States and is active in North and South America, Europe